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Circadian Variation in Vascular Function and Regenerative Capacity in
Healthy Humans
Ibhar Al Mheid, MD; Frank Corrigan, MD; Farheen Shirazi, MD; Emir Veledar, PhD; Qunna Li, MS; Wayne R. Alexander, MD, PhD;
W. Robert Taylor, MD, PhD; Edmund K. Waller, MD, PhD; Arshed A. Quyyumi, MD
Background-—Progenitor cells (PCs) are mobilized in response to vascular injury to effect regeneration and repair. Recruitment of
PCs requires intact nitric oxide (NO) synthesis by endothelial cells, and their number and activity correlate with cardiovascular
disease risk burden and future outcomes. Whereas cardiovascular vulnerability exhibits a robust circadian rhythm, the 24-hour
variation of PCs and their inter-relation with vascular function remain unknown. We investigated the circadian variation of PCs and
vascular function with the hypothesis that this will parallel the pattern observed for cardiovascular events (CVEs).
Methods and Results-—In 15 healthy subjects (9 men, 3716 years), circulating PCs and vascular function were measured at
8 AM, noon, 4 PM, 8 PM, midnight, 4 AM (only PCs counts), and 8 AM the following day. Circulating PCs were enumerated as
mononuclear cells (MNCs; CD45med) that express CD34 as well as CD133, and their activity was assessed as the number of
colonies formed by culturing MNCs. Vascular function was evaluated by measurement of endothelium-dependent, ﬂow-mediated
vasodilation (FMD) of the brachial artery and tonometry-derived indices of arterial stiffness. Higher CD34+ and CD34+/CD133+ cell
counts were observed at 8 PM than any other time of the day (P-ANOVA=0.038 and <0.001; respectively) and were lowest at 8 AM.
PC colony formation was highest at midnight (P-ANOVA=0.045) and lowest in the morning hours. FMD was highest at midnight and
lowest at 8 AM and 8 PM, and systemic arterial stiffness was greatest at 8 AM and lowest at 4 PM and midnight (P-ANOVA=0.03 and
0.01; respectively).
Conclusion-—A robust circadian variation in PC counts and vascular function occurs in healthy humans and both exhibit an
unfavorable proﬁle in the morning hours that parallels the preponderance of CVEs at these times. Whether these changes are
precipitated by awakening and time-dependent physical activity or governed by the endogenous circadian clock needs to be further
investigated. ( J Am Heart Assoc. 2014;3:e000845 doi: 10.1161/JAHA.114.000845)
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V ulnerability to adverse cardiovascular disease (CVD)events, such as myocardial ischemia, infarction, sudden
cardiac death, and cerebrovascular accidents, are subject to
an intrinsic circadian rhythm with greatest prevalence during
the morning hours.1–4 A similar circadian variability is
observed in likely physiological precipitants, including heart
rate and blood pressure (BP), vasoconstrictor tone, blood
viscosity and ﬁbrinolytic activity, platelet aggregability,
epinephrine and norepinephrine levels, in addition to cortisol
levels and plasma renin activity.5–12
Other precipitants of CVD events include impaired endo-
thelial cell (EC) function and increased systemic arterial
stiffness, which precede and contribute to the development of
CVD and are long-term predictors of morbidity and mortal-
ity.13 Indeed, vascular dysfunction and reduced nitric oxide
(NO) bioavailability promote a proinﬂammatory and -coagula-
tory milieu that also triggers acute vascular events.13,14
Whereas several studies conﬁrm the presence of signiﬁcant
changes in vascular endothelial function by the time of day,
which may differ between patient populations, others dem-
onstrate no signiﬁcant circadian or diurnal variation.15–21
Recently, bone-marrow (BM)-derived progenitor cells (PCs)
have been identiﬁed and quantitated in the circulation. PCs
are released into the bloodstream in response to vascular
injury, homing to areas of ischemia, and actively participate in
tissue repair and regeneration.22 In experimental models,
mobilization of PCs is dependent on endothelial nitric oxide
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synthase (eNOS) activity and bioavailability of NO.23 In
humans, recruitment of PCs into the circulation is modulated
by the burden of CVD and its risk factors, and lower counts
predict adverse outcomes.24–29Signiﬁcant circadian variation
of circulating PCs in hospitalized patients and diurnal changes
over 2 or 3 time points have been observed30,31; however,
their detailed 24-hour variability and relationship to changes
in vascular function remain unknown.26
The aim of our study was to investigate the circadian
variation of circulating PC counts and their in vitro proangi-
ogenic activity, measured using a colony formation assay, in
relation to changes in endothelium-dependent and -indepen-
dent measures of vascular function and arterial stiffness in
healthy subjects. We hypothesized that PC counts and
activity, in addition to endothelial function and arterial
stiffness, have signiﬁcant circadian variation that parallels
the risk of CVD events.
Methods
Subjects
Fifteen healthy nonsmoking subjects were recruited after
careful screening to include only normotensive (systolic
arterial pressure<140 or diastolic pressure<90 mm Hg),
normolipidemic (total cholesterol level<200 and low-density
lipoprotein<120 mg/dL), normoglycemic (fasting glucose<
100 mg/dL), and nonobese subjects (body mass index≤25)
subjects. Other exclusion criteria included pregnancy, history
of CVD or chronic illnesses, or intake of medications over
4 weeks preceding screening. This study was approved by the
Emory University Investigational Review Board and subjects
gave informed consent.
Subjects were instructed to adhere to a regular wake-
sleep cycle (no later than 7 AM and 11 PM, respectively) for
at least 2 weeks before the study. On the evening
preceding testing, subjects were admitted to the Atlanta
Clinical and Translational Science Institute (ACTSI) at Emory
University Hospital, and an intravenous catheter was placed
and maintained in the nondominant arm for the duration of
the study. Lights were turned off at 11 PM, and testing
started at 7:30 AM the following morning. Blood draws and
vascular measurements were repeated at 4-hour intervals
(except for vascular testing at 4 AM) and took approximately
1 hour to complete. Standardized, low-fat meals prepared
by the ACTSI food services were provided to participants
after study measurements at the 8:00 AM, 12:00 PM, and
6:00 PM time points, with a minimum of 4 hours separating
consecutive meals. Subjects abstained from caffeinated
beverages and were allowed to engage only in sedentary
activities.
Circulating Progenitor Cell Counts and
Proangiogenic Activity
Peripheral blood mononuclear cell subsets that are consid-
ered to be enriched for hematopoietic and endothelial
progenitors were measured in CD45med cells expressing
CD34+, CD133+, and vascular endothelial growth factor
receptor 2 (VEGFR2)+ surface markers, either singly or in
combination. The CD34+ population represents hematopoi-
etic progenitors, and the CD34+/CD133+ subset are
immature or early progenitors, because the CD133 epitope
disappears as PCs mature.32 The VEGFR2+ cell population
exhibits an intact VEGFR2 receptor, indicating these cells’
capability to participate in angiogenesis and vasculogensis.
We measured circulating numbers of CD34+, dual-positive
CD34+/CD133+ and CD34+/VEGFR2+, and triple-positive
CD34+/CD133+/VEGFR2+ cell populations.
Flow cytometry
Peripheral blood PCs were analyzed for the expression of
surface antigens using direct ﬂow cytometry (FCM; BD FACS
Canto II Flow Cytometer; BD Biosciences, San Jose, CA).
Three hundred microliters of venous blood (anticoagulant:
EDTA) was incubated with ﬂuorochrome-labeled monoclonal
mouse antihuman antibodies, namely, FITC-CD34 (BD Bio-
sciences), PE-VEGF2R (also known as kinase insert domain
receptor; R&D Systems, Minneapolis, MN), and APC-CD133
(Miltenyi Biotec, Bergisch Gladbach, Germany) for 15 min-
utes. Red blood cells were removed by lysis in 1.5 mL of
ammonium chloride lysing buffer, which was added to the
sample and incubated for an additional 10 minutes. The lysis
process was stopped by adding 1.5 mL of staining medium
(PBS with 3% heat-inactivated serum and 0.1% sodium
azide). Five million events were acquired from the cytometer
with FlowJo software (Treestar, Inc., Ashland, OR) used for
subsequent analysis of accumulated data. Absolute numbers
of each cell subset per milliliter were determined by
multiplying the counts with the number of monocytes per
milliliter of blood.
Reproducibility testing
Twenty samples were repeatedly analyzed on 2 occasions by
2 technicians to assess for reproducibility. The percent
repeatability coefﬁcients (%) were calculated as SD of
differences between pairs of measurements/mean of mea-
surements9100. The repeatability coefﬁcients for the various
cell types were: CD34+, 7.4%; CD133+, 7.0%; CD34+/CD133+,
4.4%; CD34+/VEGFR2+, 16.3%; and CD34+/CD133+/VEG-
FR2+, 19.2%.
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Colony-forming assay
To assess proangiogenic activity of circulating PCs, we
performed a culture assay that quantiﬁes colony formation
units (CFUs) from mononuclear cells (MNCs), as detailed
previously.33,34 This assay measures BM-derived precursor
cells that mature into both proangiogenic hematopoietic- and
endothelial-like cells, serving as a biomarker of a “combined”
proangiogenic cell activity.
In brief, MNCs were isolated by density-gradient centrifu-
gation from a 20-mL sample of blood using CPT (Becton
Dickinson, Franklin Lakes, NJ) tubes, suspended in growth
medium (DMEM supplemented with 20% FBS and 6.5% EC
growth supplement) and plated on dishes coated with human
ﬁbronectin (Biocoat; Becton Dickinson). To eliminate mature
circulating ECs, cells adherent after 24 hours were discarded
and nonadherent cells were replated onto new ﬁbronectin-
coated six-well plates (1 million cells per well). Growth medium
was changed every 2 days. Colonies, identiﬁed as multiple
thin, ﬂat cells emanating from central clusters of rounded cells,
were counted 7 days after plating by a blinded observer and
reported as the number of CFUs per 1 million cells.
Reproducibility was tested by measuring CFUs in 15
samples drawn 1 week apart from the same individuals. The
overall correlation between the repeated assays was 0.84,
and the mean number of colonies in each of the duplicates
was 484 versus 503.
Proliferation assay
To determine whether the colonies were derived from mono-
nuclear precursor cells by proliferation, 5-bromo-20-deoxyuri-
dine (BrdU; 1 lg/mL; Sigma-Aldrich, St. Louis, MO) was used to
label cells for 24 hour on day 3 or 6 of growth. Subsequently,
immunostaining with anti-BrdU (Dako, Carpinteria, CA) was
used to detect proliferating cells within the colonies.
Reverse-transcriptase polymerase chain reaction
RNA was isolated from freshly isolated MNCs and from 7-day
colonies using the Qiagen RNeasy Mini Kit (Qiagen, Valencia,
CA). cDNA was prepared from RNA samples, and reverse-
transcriptase polymerase chain reaction (RT-PCR) was per-
formed in an ABI 7900 (Applied Biosystems, Foster City, CA).
RT-PCR was performed in an ABI 7900 (Applied Biosystems)
instrument using pathway-focused gene expression PCR
arrays from Super Array (human endothelial biology, angio-
genesis). mRNA expression levels were determined using
SYBR Green–based real-time PCR. Results were analyzed
using the PCR Array data analysis Web portal to convert
threshold cycles into fold changes.
Immunocytochemistry
We performed immunocytochemistry (ICC) for leukocyte and
endothelial antigens. Seven colonies were ﬁxed in 2%
paraformaldehyde for 1 hour, washed in PBS, and blocked
with 5% normal serum in 2% BSA in PBS for 30 minutes. Cells
were incubated with the primary antibody (mouse anti-CD31,
1:300; eBioscience, San Diego, CA), mouse anti-CD45
(1:5000; eBioscience), mouse anti-CD3 (1:300; eBioscience),
mouse anti-CD14 (1:200; Santa Cruz Biotechnology, Santa
Cruz, CA), mouse anti–vascular endothelial (VE) cadherin
(1:50; Abcam, Cambridge, UK), rabbit polyclonal anti-eNOS
(1:1000; Santa Cruz Biotechnology), and rabbit polyclonal
anti–von Willibrand’s factor (vWF; 1:1000; Chemicon, Teme-
cula, CA) in 2% BSA for 1 hour and then with biotinylated horse
anti-mouse immunoglobulin G (IgG) for monoclonal primary
antibodies and biotinylated goat anti-rabbit IgG for polyclonal
antibodies (1:200; Vector Laboratories, Burlingame, CA) for
30 minutes. After another PBS wash, cells were stained with
streptavidin-conjugated quantum dots (QDot 605; 1:100;
Invitrogen, Carlsbad, CA) for 1 hour and counterstained with
Hoechst nuclear stain. Images were acquired on a Zeiss LSM
510 confocal microscope (Carl Zeiss, Jena, Germany).
To detect the surface expression of endothelial and
hematopoietic lineage marker proteins, harvested colonies
from 24-well plates were suspended in PBS after washing and
incubated for 1 hour in the presence of the anti-CD14, -CD3,
-CD45, -eNOS, -vWF, or -VE cadherin and then conjugated
with biotinylated secondary antibodies. After washing with
PBS, cells were stained with streptavidin-conjugated quantum
dots (QDot 605; Invitrogen), 1:100, and analyzed by FCM
(FACSCalibur; Becton Dickinson).
ICC and FCM demonstrated cells expressing both leukocyte
and endothelial antigens (80%of cells expressingCD45and20%
of cells expressing eNOS and vWF), whereas reverse transcrip-
tase demonstrated high levels of expression of proangiogenic
factors as well as capillary-like tubes formed in culture.
Assessment of Vascular Function
After blood draw and an initial rest period of 10 minutes and
with subjects in a supine position in a quiet, temperature-
controlled room, BP was measured 3 times at 5-minute
intervals by an automatic device (Omron, Kyoto, Japan) from
the dominant arm and documented as the mean value of the
ﬁnal 2 measurements.
Arterial stiffness
We utilized the augmentation index (AIX) and carotid-femoral
pulse wave velocity (PWV) for assessment of arterial wave
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reﬂections and stiffness, derived using the SphygmoCor device
(Atcor Medical, Sydney, Australia), as previously described.35
Brieﬂy, high-ﬁdelity sequential pressure waveforms were from
the radial artery using a tonometer. Using a transfer function,
central (aortic) pressure and the degree of pressure augmen-
tation secondary to reﬂected waves from the periphery was
estimated. AIX was then derived as augmented pressure/total
central pulse pressure and was considered a composite marker
of wave reﬂections and arterial stiffening. Because of its
sensitivity to heart rate, a standardized value to 75 bpm was
calculated and used for AIX for the purpose of this study.
PWV was determined by acquiring waveforms at the
carotid and femoral arterial sites using EKG gating. Velocity
(distance/time in m/s) was calculated by measuring the time
interval between EKG R-waves and the recorded waveforms
at each site, whereas distance between sites was measured
manually. Quality control indices were evaluated at the time of
study and nonacceptable readings discarded and tests were
repeated. Reproducibility studies in our laboratory on 9
subjects on consecutive days have demonstrated a coefﬁcient
of variation of 3.8%, 20.3%, and 13.8% for PWV, AIX, and
subendocardial viability ratio, respectively.
Brachial artery ﬂow-mediated dilatation
Endothelium-dependent brachial artery ﬂow-mediated dilata-
tion (FMD) was measured to evaluate endothelium-depen-
dent vasodilation, as previously described.35 Brieﬂy,
sonographic images showing a clear intima-media/adventi-
tia interface, in addition to pulse Doppler velocities, were
obtained before and after suprasystolic cuff occlusion at
the forearm. FMD was calculated as the percent dilation
observed at 1 minute after cuff release. In our laboratory,
the mean difference in FMD between assessments per-
formed in 11 subjects on consecutive days was
1.260.76%, with a correlation coefﬁcient of 0.75. The
mean difference in FMD between 2 readings of the same
11 measurements was 0.820.48% (r=0.97).
Statistical Considerations
Study variables are described as the meanSD for continuous
variables, or as counts or proportions for categorical
variables. To account for interindividual differences, mean
values of study variables were calculated for each subject and
used to determine percent deviation (%D) from the individual
mean at every time point. A cubic (natural) spline function was
used to smooth the interpolation line connecting different
time points. Analyses were performed using SPSS (version
21.0; SPSS, Inc., Chicago, IL).
Age, BP, heart rate, FMD, AIX, PCs, and CFUs were treated
as continuous variables. Gender and time points were
categorical variables, and group differences were determined
by independent or paired t tests, as appropriate. One-way
ANOVA was utilized to examine differences in study variables
across times points. Repeated-measures ANOVA was used to
determine within-subject differences. For each study mea-
sure, Greenhouse-Geisser’s correction was applied because
Mauchly’s test of sphericity was signiﬁcant in all variables.
The P values on Figure 3 were derived from paired t tests
between 2 time points.
Data presented in Table 2 were derived from Tukey’s post-
hoc honest signiﬁcant differences (HSD) between the time
point at which peak values were observed and other times of
the day.
Results
Baseline characteristics of study subjects are summarized in
Table 1. The mean age of participants was 37 years, ranging
from 21 to 67 years, 6 (40%) women, and 4 (27%) African-
American subjects. Subjects were free of CVD risk factors.
Circadian Variation in Hemodynamic
Measurements
Arterial BP and heart rate measurements did not vary
signiﬁcantly by the time of day. Mean arterial pressure
ranged between 87.47.1 and 90.411 mm Hg, and mean
resting heart rate was between 58.611 and 61.610.5 bpm
(Figure 1).
Circadian Variation in PC Count
There were signiﬁcant circadian variations in circulating
CD34+ (P=0.038) and dual-positive CD34+/CD133+
(P<0.001) counts by ANOVA, where counts were lowest at
8 AM and highest at 8 PM, with a difference of 551175 and
41285 cells/mL, respectively (Figure 1A,1B; Table 2). To
account for interindividual differences, percent change from
the individual mean was calculated for each subject. The
percent change from the individual mean for CD34+ and
CD34+/CD133+ PCs was lowest at 8 AM (1127% and
3031%, respectively) and greatest at 8 PM (2426%,
and 4440%, respectively; (Figure 2A,2B).
Similarly, within-subject differences were evaluated by
repeated-measures ANOVA with Greenhouse-Geisser’s cor-
rection revealing signiﬁcant differences in CD34+ and CD34+/
CD133+ counts by the time of day (F=2.73 and 8.09; P=0.046
and <0.001, respectively).
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Although a similar trend was observed in CD34+/VEGFR2+
and CD34+/CD133+/VEGFR2+ cell counts, these changes
were not statistically different (P-ANOVA=0.09 and 0.1,
respectively).
Circadian Variation in CFUs
There was a signiﬁcant circadian variation in CFU counts
across the 24-hour period (P-ANOVA=0.045; n=11), with the
highest mean count (25.214.5) observed at midnight,
compared to the nadir at 8 AM (13.214.5; Figure 2C).
Within-subject differences were evaluated by repeated-
measures ANOVA with Greenhouse-Geisser’s correction
revealing signiﬁcant differences by the time of day
(F=3.96; P=0.014).
The precent change from individual means was highest at
midnight and lowest at 8 AM (5436% and 3638%,
respectively; Table 2).
Circadian Variation in Endothelial Function
There was a signiﬁcant circadian variation in endothelial
function (P-ANOVA=0.028), where brachial artery FMD
peaked at midnight (5.92.2%). The percent change from
the individual mean was greatest at midnight (30.434) and
lowest at 8 AM and 8 PM (9.931% and 1128.8%,
respectively; Figure 3A). Repeated-measures ANOVA
with Greenhouse-Geisser’s correction revealed signiﬁcant
within-subject differences by the time of day (F=3.38;
P=0.047).
Circadian Variation in Arterial Wave Reﬂections
There was a signiﬁcant circadian variation in AIX (P-ANO-
VA=0.014), with it being highest at 8 AM (22.28.4; Fig-
ure 3B). The percent change from the individual mean was
highest at 8 AM (31.839.3%) and lowest at midnight
(33.532.8%; Figure 3B). Differences evaluated by
repeated-measures ANOVA with Greenhouse-Geisser’s cor-
rection conﬁrmed signiﬁcant within-subject differences by the
time of day (F=7.32; P=0.001).
There was no signiﬁcant circadian variation in PWV
measurements, and the peak-to-nadir deviation did not
exceed 30% in any of the subjects.
Post-Hoc Analysis
Table 2 shows Tukey’s post-hoc HSD between the time point
at which peak values were observed and other times of the
day. There were signiﬁcant within-subject differences in PC
counts, endothelial FMD, and AIX between values observed
at 8 AM and the time point at which the highest CD34+ and
CD34+/CD133+ cell counts (8 PM) and at which peak FMD
and lowest AIX (12 AM) were observed (P<0.01 for all;
Figure 4).
Table 1. Demographic and Clinical Characteristics of Study
Participants
Age, y 36.916
Gender
Women 6 (40%)
Men 9 (60%)
Race
White 9 (60%)
Black 4 (27%)
Height, m 1.710.08
Weight, kg 68.910.5
Body mass index, kg/m2 23.92.2
Heart rate, bpm 609.8
Systolic blood pressure, mm Hg 1179
Diastolic blood pressure, mm Hg 7210
Mean arterial pressure, mm Hg 86.77.8
Low-density lipoprotein, mg/dL 9222
Triglycerides, mg/dL 6027
Glucose, mg/dL 817
White blood count, cells/mL 4912689
Hemoglobin, g/dL 14.41.6
Values are expressed as meanSD, N=15.
Figure 1. Circadian variation in hemodynamic parameters.
Meanstandard error (SE) of heart rate (HR), diastolic blood
pressure (DBP), and systolic blood pressure (SBP). P-ANOVA:
nonsigniﬁcant (>0.05) for all, N=15. MAP indicates mean arterial
pressure.
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Discussion
In this study of healthy subjects, we assessed the circadian
variation of PC number and activity and their temporal
relationship with the circadian variation in vascular function,
measured as both endothelium-dependent vasodilation and
arterial wave reﬂections/stiffness. We observed that the
number of circulating PCs, measured as CD34+ and CD34+/
CD133+ cell counts, and their proangiogenic activity, mea-
sured as CFUs in culture, were lowest in the early morning
hours (8 AM). This coincided with the time when endothelial
NO activity was lowest and arterial stiffness, measured as
AIX, was greatest. We also found that PC counts were
highest at 8 PM, and their proangiogenic activity was highest
at midnight. In parallel, FMD was highest, and AIX was
lowest, at midnight.
For the ﬁrst time, to our knowledge, we have demon-
strated a simultaneous and parallel 24-hour circadian
variation in vascular function and PC numbers and activity.
Our ﬁndings suggest that endogenous reparative or regen-
erative capacity varies by the time of day that may be
related to, or reﬂected by, changes in vascular function.
Whether these changes are the result of morning increases
in physical activities after awakening (e.g., postural
changes, mental activities, food intake, etc.) or are
determined by an intrinsic circadian rhythm that is
entrained over longer time periods (weeks or months)
needs to be further investigated.
Table 2. Tukey’s Post-Hoc Honest Signiﬁcant Differences (HSD) Between Peak and Values Observed at Other Times of the Day
Time Point of Highest Value Other Time Points Mean Difference Signiﬁcance
CD34+, cells/mL 8 PM 8 AM 551.49* 0.04
12 PM 313.07 0.56
4 PM 414.08 0.23
12 AM 362.91 0.38
4 AM 506.53 0.07
8 AM 522.3 0.06
CD34+CD133+, cells/mL 8 PM 8 AM 412.28* <0.001
12 PM 300.89* 0.01
4 PM 163.2 0.48
12 AM 161.53 0.49
4 AM 347.34* <0.001
8 AM 315.56* 0.01
CFU, D% 12 AM 8 AM 68.19* 0.005
12 PM 44.34 0.16
4 PM 58.31* 0.02
8 PM 64.85* 0.008
8 AM 90.93* <0.001
FMD, D% 12 AM 8 AM 40.21* 0.014
12 PM 37.65* 0.02
4 PM 24.57 0.31
8 PM 42.04* 0.01
8 AM 37.69* 0.017
AIX, D% 8 AM 12 PM 45.80* 0.04
4 PM 57.84* 0.003
8 PM 9.57 0.99
12 AM 65.28* <0.001
8 AM 12.03 0.97
D %=percent deviation from the individual mean. AIX indicates augmentation index; CFU, colony formation units; FMD, ﬂow-mediated vasodilation.
*Denotes statistically signiﬁcant difference between the time point of highest value and other individual time points, based on the 2-tailed P values (signiﬁcance) for the studentized range
statistic.
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A B C
Figure 2. Circadian variation in (A) CD34+ and (B) CD34+/CD133+ (C) colony forming unit (CFU) counts. Bottom box plots: middle band
represents median, bottom and top of the box represent lower and upper quartiles, and whiskers represent highest and lowest values that are
not outliers. Top: average percent deviation (D%) from the individual mean. P values are for ANOVA, N=15 for A and B, N=11 for C.
A B
Figure 3. Circadian variation in (A) brachial artery FMD and (B) AIX. FMD, brachial artery
ﬂow-mediated dilation (%). AIX, augmentation index. Bottom box plots: middle band
represents median, bottom and top of the box represent lower and upper quartiles, and
whiskers represent highest and lowest values that are not outliers. Top ﬁgures show
average percent deviation (D%) from the individual mean. P values are for ANOVA, N=15.
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We and others have previously shown circadian changes in
vascular function that are similar to those observed in our
subjects.5,15 In only 2 previous studies, diurnal variation over
3 time points in PC counts in selected subjects have been
investigated. The circulating CD34+/CD133+ cell count was
higher at midnight than at noon or 6 PM in elderly inpatients,30
and higher PCs counts were observed at 10 PM, compared to
8 AM and 3 PM, in healthy men.31 These results are in line with
our ﬁndings that detail the full 24-hour variation in PC counts
in this study involving healthy men and women and further
investigates circadian changes in their proangiogenic activity
during culture.
Circulating PCs exhibited a single clear peak at 8 PM, and
nadir values were observed in the morning hours. These
pronounced differences (approximately 60% for CD34+/
CD133+ cells) are not surprising in light of circadian changes
of a similar magnitude in cytokines that mobilize BM
progenitors, including granulocyte-colony stimulating factor
and erythropoietin. The circadian pattern of these cytokines
also parallels that of PCs, with marked evening increases,
and is similarly observed in other peripheral blood compo-
nents, such as the total circulating granulocyte or lympho-
cyte counts.36–40 PC mobilization is partly dependent on
NO availability, which also exhibits signiﬁcant circadian
changes.41,42
Several mechanisms may dictate the circadian pattern of
PC egress from the BM, their circulating counts, and
translocation into peripheral tissues,40,43 but the concomitant
morning worsening of vascular function measurements and
decrease in PC counts can be best explained by the surge of
sympathetic nervous system activity observed in the morning
hours. Indeed, sympathetic activity has been shown to
blunt NO-mediated vasodilation and increase vascular tone,
as well as regulate trafﬁcking of PCs by adrenergic receptor
activation.23
Although some studies propose a counter-regulatory
effect of enhanced endothelial function that may mitigate
circadian increases in vascular tone,21,44 our ﬁndings
demonstrate simultaneous worsening of brachial artery
FMD and systemic arterial stiffness. Furthermore, AIX
exhibited a lesser peak at 8 PM, alongside a signiﬁcant
decline in FMD at that same time point (Table 2). However,
Figure 4. Time points at which peak and nadir values of progenitor cell counts, AIX, and
brachial artery FMD were observed. AIX indicates augmentation index; FMD, brachial artery
ﬂow-mediated dilation (%). P values are for paired t tests, N=15.
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the extent of improvements or worsening in arterial
stiffness or wave reﬂections did not correlate with those
in FMD at each time point. Nonetheless, both vascular
function and PC counts exhibited an unfavorable morning
proﬁle with depressed PC counts and greater endothelial
dysfunction, as well as increased arterial stiffness. This is
also in agreement with recent ﬁndings of a possible lower
hemostatic “set point” for vascular function parameters
after a period of sleep.45
Limitations
Our study size may have been too small to detect circadian
changes in rare cell populations (CD34+/VEGFR2+/CD133+
cells). Although both men and women across a wide age
range were included, this study was designed to elucidate
circadian changes in healthy individuals, thus limiting the
generalizability of our ﬁndings. Similar to several other
physiologic parameters, circadian variation in PC counts or
vascular function may be blunted or accentuated in
speciﬁc disease conditions, and this requires further
investigation.
Whereas continuous wall motion tracking might have
identiﬁed circadian variability in the postdeﬂation timing of
the maximal dilatory responses, which may be vary by age,46
we used the 1-minute time point to determine brachial artery
ﬂow-mediated dilation because of this technique’s high
reproducibility and short duration.
This present study was not designed to detect BP or heart
rate changes; however, we did not expect the absence of
signiﬁcant circadian changes. Although these measurements
were performed before vascular testing, which required
walking to the vascular lab and interrupted an otherwise
sedentary day, subjects underwent an initial rest period of at
least 10 minutes. Hemodynamic measurements were also
performed after blood draws and, together with vascular
testing, might have exerted a “white coat effect” on these
measurements.
The study included 6 women (mean age of 28; range, 23 to
38 years), and all were premenopausal. Thus, differences that
may occur after menopause cannot be addressed in this
study. We studied these female participants a few days after
cessation of menstruation to reduce known variability during
the menstrual cycle.47
Subjects were instructed to maintain a regular sleep-wake
cycle over 2 weeks preceding the study, but compliance could
only be ascertained by self-report. Nevertheless, subjects
were admitted the night before commencement of the study
and lights were turned off by 11 PM at the latest. Moreover, all
subjects were awakened by 7 AM and standardized meals
were served at a ﬁxed time for all participants. Last, because
sedentary activities (reading, watching television) were
allowed, unidentiﬁed factors related to these activities might
have affected our results.
Conclusion
In summary, our ﬁndings highlight the robust circadian
variations in potential underlying precipitants of CVD events,
which parallel their morning preponderance. This is evi-
denced by the paucity of peripheral blood PCs, as well as
worsened NO-dependent vasodilation and increased vascular
stiffness.
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